Abstract
Type 2 diabetes is the commonest form of diabetes constituting 90% of the diabetic population. The global prevalence of diabetes is estimated to increase from 4% in 1995 to 5.4% by the year 2025. Diabetic nephropathy is a major cause of illness and death in diabetes. The excess of cardiovascular events and mortality occurs already in diabetic patients with persistent microalbuminuria.
| Original language | English |
|---|---|
| Pages (from-to) | 358-363 |
| Number of pages | 6 |
| Journal | Research Journal of Pharmaceutical, Biological and Chemical Sciences |
| Volume | 2 |
| Issue number | 1 |
| Publication status | Published - 01-01-2011 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
All Science Journal Classification (ASJC) codes
- General Biochemistry,Genetics and Molecular Biology
- Pharmacology, Toxicology and Pharmaceutics(all)
Fingerprint
Dive into the research topics of 'Significance of microalbuminuria in cardiovascular disease and nephropathy in diabetic patients'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver